NUTEX HEALTH INC. (NUTX) Gross margin 2017–2025
NUTEX HEALTH INC. (NUTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
50.8%FY2025 · since FY2017: -31.6% → 50.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 50.8% | +9.9 pp |
| FY2024 | 40.9% | +26.9 pp |
| FY2023 | 14.0% | +7.0 pp |
| FY2022 | 7.0% | -47.0 pp |
| FY2021 | 54.1% | -3.4 pp |
| FY2020 | 57.5% | +18.3 pp |
| FY2019 | 39.2% | -23.6 pp |
| FY2018 | 62.9% | +94.4 pp |
| FY2017 | -31.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NUTX financial trends
NUTX RevenueNUTX Net incomeNUTX Net marginNUTX Gross profitNUTX Operating incomeNUTX Operating marginNUTX Operating cash flowNUTX Free cash flowNUTX Capital expendituresNUTX Return on equityNUTX Stock buybacksNUTX Dividends paidNUTX Total assetsNUTX Total liabilitiesNUTX Shareholders’ equityNUTX overview →